About: BCAL Diagnostics Limited, a biotechnology company, engages in developing a novel blood screening test to support the early diagnosis and monitoring of breast cancer in Australia. It is involved in the development and commercialization of BREASTESTplus; Avantect Pancreatic; Avantect Ovarian; BREASTESTplus 2; BREASTEST Monitor; and Avantect multi-cancer test. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.07 (-16.67%)
BDX ASX Bcal Diagnostics Ltd
Bcal Diagnostics Ltd share price
BDX price activity
Last Price
$0.070
Change (24hr)
-0.01 AUD (16.67%)
Volume
7.50K
Volume (4w avg)
-
Open
$0.07
Day Range
$0.07 - $0.07
Previous Close
$0.08
Last Trade
03 Nov, 12:35 am GMT+0
Delayed
03 Nov, 12:35 am GMT+0
BDX price performance
Delayed
03 Nov, 12:35 am GMT+0
BDX details
BDX Market Signals